Luca Mastorino
1,2*
SIMONE RIBERO
2
Martina Burlando
3
Pedro Mendes-Bastos
4The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Med.
Sec. Dermatology
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1473753
This article is part of the Research Topic Patients-Oriented Treatments for Chronic Inflammatory Skin Diseases View all 8 articles
Editorial: Patients-Oriented Treatments for Chronic Inflammatory Skin Diseases
Provisionally accepted- 1 University of Turin, Turin, Italy
- 2 Department of Medical Sciences, School of Medicine, University of Turin, Turin, Piedmont, Italy
- 3 Ospedale Policlinico San Martino, Genova, Italy
- 4 CUF Descobertas Hospital, Lisbon, Portugal
Keywords: Psoriasis, Hidradenitis suppurativa - acne inversa - therapy, atopic dermatitis, biologics, Bimekizumab, Brodalumab, Supplement, Hidradenitis suppurativa (HS)
Received: 31 Jul 2024; Accepted: 30 Aug 2024.
Copyright: © 2024 Mastorino, RIBERO, Burlando and Mendes-Bastos. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Luca Mastorino, University of Turin, Turin, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.